» Articles » PMID: 25858567

Signal Identification in Addictovigilance: the Functioning of the French System

Overview
Journal Therapie
Specialty Pharmacology
Date 2015 Apr 11
PMID 25858567
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The French addictovigilance network (addictovigilance: surveillance of addiction), composed of 13 Addictovigilance Centres, was set up in 1990 in order to achieve reliable surveillance and evaluation of abuse and dependence cases due to psychoactive substances (alcohol and tobacco excepted). The detection of safety signals is one of the roles of the addictovigilance centres. Signals from spontaneous reports need to be analyzed before further communication. In addictovigilance, signals may be linked to adverse effects (deaths, pathological signs), to products (new psychoactive substances with potentially dangerous effects) or to practices (new administration routes, new contexts of use). These signals are provided by numerous partners among whom the addictovigilance network has to raise awareness about information that may possibly be an alert signal. The watchful attitude of all partners will make it possible that signals will be, after analyze, considered as true alerts. The addictovigilance network collects data, assess the potential for addiction of psychoactive drugs to provide information on the risk of addiction and give opinions for public health decisions (harm reduction or prevention programs, psychoactive substances control, health alerts).

Citing Articles

Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register.

Revol B, Willeman T, Manceau M, Dumestre-Toulet V, Gaulier J, Fouilhe Sam-Lai N JAMA Netw Open. 2023; 6(8):e2331398.

PMID: 37647066 PMC: 10469283. DOI: 10.1001/jamanetworkopen.2023.31398.


Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?.

Bertin C, Montigne E, Teixeira S, Ferrer F, Lauwerie L, Richard D Harm Reduct J. 2023; 20(1):59.

PMID: 37106464 PMC: 10134660. DOI: 10.1186/s12954-023-00781-2.


Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.

Bouquet E, Eiden C, Fauconneau B, Pion C, Pain S, Perault-Pochat M Sci Rep. 2022; 12(1):16509.

PMID: 36192621 PMC: 9530152. DOI: 10.1038/s41598-022-19197-2.


Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users.

Laforgue E, Rousselet M, Claudon A, Aquizerate A, Jolliet P, Istvan M Int J Environ Res Public Health. 2022; 19(15).

PMID: 35897285 PMC: 9331950. DOI: 10.3390/ijerph19158920.


Ten-year trends in hospitalizations related to cocaine abuse in France.

Eiden C, Roy S, Malafaye N, Lehmann M, Peyriere H Fundam Clin Pharmacol. 2022; 36(6):1128-1132.

PMID: 35801616 PMC: 9796279. DOI: 10.1111/fcp.12815.